Cargando…
Outcome reporting bias in randomized-controlled trials investigating antipsychotic drugs
Recent literature hints that outcomes of clinical trials in medicine are selectively reported. If applicable to psychotic disorders, such bias would jeopardize the reliability of randomized clinical trials (RCTs) investigating antipsychotics and thus their extrapolation to clinical practice. We ther...
Autores principales: | Lancee, M, Lemmens, C M C, Kahn, R S, Vinkers, C H, Luykx, J J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639247/ https://www.ncbi.nlm.nih.gov/pubmed/28895941 http://dx.doi.org/10.1038/tp.2017.203 |
Ejemplares similares
-
Selective outcome reporting across psychopharmacotherapy randomized controlled trials
por: Lancee, Michelle, et al.
Publicado: (2021) -
Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial
por: de Boer, Nini, et al.
Publicado: (2021) -
Attentional bias modification training for insomnia: A double-blind placebo controlled randomized trial
por: Lancee, Jaap, et al.
Publicado: (2017) -
Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real‐World Study Across Antipsychotics
por: Stam, Noraly, et al.
Publicado: (2020) -
Pharmacogenetics and outcome with antipsychotic drugs
por: Pouget, Jennie G., et al.
Publicado: (2014)